New Key Statistics Module, Z-Score and F-Score
OTCPK:MEDIF Key Ratios
| Market Cap $ M | 20.75 |
| Enterprise Value $ M | 11.24 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.60 |
| Price/Sales | 0.77 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 27.00 |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -3.32 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.18 |
| EV-to-EBITDA | -1.51 |
| PEG | -- |
| Shares Outstanding M | 411.07 |
| Net Margin (%) | -35.72 |
| Operating Margin % | -34.65 |
| Pre-tax Margin (%) | -36.45 |
| Quick Ratio | 2.33 |
| Current Ratio | 3.11 |
| ROA % (ttm) | -20.65 |
| ROE % (ttm) | -25.48 |
| ROIC % (ttm) | -29.84 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.45 |
MEDIF Number of Guru Trades
MEDIF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MEDIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MEDIF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
MediPharm Labs Corp Insider Transactions
No Available Data
News about OTCPK:MEDIF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers